Centrient Pharmaceuticals Overview

  • Year Founded
  • 1868

Year Founded

  • Status
  • Private

  • Employees
  • 1,800

Employees

  • Latest Deal Type
  • Debt Refin.

  • Financing Rounds
  • 6

  • Investments
  • 1

Centrient Pharmaceuticals General Information

Description

Manufacturer of sustainable antibiotics, next-generation statins and antifungals intended to fight against antimicrobial resistance. The company specializes in the production and commercialization of sustainable antibiotics and intermediates, active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs), enabling its clients to meet their sustainable and accessible pharmaceutical needs effectively.

Contact Information

Formerly Known As
DSM Anti Infectives, DSM Sinochem Pharmaceuticals
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Weena 798 E-F
  • 3014 DA Rotterdam
  • Netherlands
Primary Industry
Pharmaceuticals
Corporate Office
  • Weena 798 E-F
  • 3014 DA Rotterdam
  • Netherlands

Centrient Pharmaceuticals Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Centrient Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Centrient Pharmaceuticals‘s full profile, request access.

Request a free trial

Centrient Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of sustainable antibiotics, next-generation statins and antifungals intended to fight against antimicrobial
Pharmaceuticals
Rotterdam, Netherlands
1,800 As of 2026

Bangalore, India
 

Hyderabad, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Centrient Pharmaceuticals Competitors (9)

One of Centrient Pharmaceuticals’s 9 competitors is Sayre Therapeutics, a Formerly VC-backed company based in Bangalore, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sayre Therapeutics Formerly VC-backed Bangalore, India
MSN Laboratories Private Debt Financed Hyderabad, India
Glenmark Pharmaceuticals Corporation Mumbai, India
Intas Pharmaceuticals Private Equity-Backed Ahmedabad, India
Paratek Pharmaceuticals Private Equity-Backed King of Prussia, PA
You’re viewing 5 of 9 competitors. Get the full list »

Centrient Pharmaceuticals Patents

Centrient Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026195815-A1 Process for producing compounds free of nitrosamine impurities Pending 20-Mar-2025
WO-2026195818-A1 Process for producing sitagliptin free of nitrosamine impurities Pending 20-Mar-2025
WO-2025052002-A1 Method for hydroxylation of bile acids or analogues thereof Inactive 08-Sep-2023
WO-2021094458-A1 Novel broad range beta-lactamases Inactive 12-Nov-2019
EP-3430153-A1 Mbth-like proteins in eukaryotic nrps-catalyzed processes Inactive 14-Apr-2016 C07K14/195
To view Centrient Pharmaceuticals’s complete patent history, request access »

Centrient Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Centrient Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Centrient Pharmaceuticals‘s full profile, request access.

Request a free trial

Centrient Pharmaceuticals Investments (1)

Centrient Pharmaceuticals’s most recent deal was a Buyout/LBO with Astral SteriTech. The deal was made on 31-Aug-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Astral SteriTech 31-Aug-2021 Buyout/LBO Drug Delivery
To view Centrient Pharmaceuticals’s complete investments history, request access »

Centrient Pharmaceuticals FAQs

  • When was Centrient Pharmaceuticals founded?

    Centrient Pharmaceuticals was founded in 1868.

  • Where is Centrient Pharmaceuticals headquartered?

    Centrient Pharmaceuticals is headquartered in Rotterdam, Netherlands.

  • What is the size of Centrient Pharmaceuticals?

    Centrient Pharmaceuticals has 1,800 total employees.

  • What industry is Centrient Pharmaceuticals in?

    Centrient Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Centrient Pharmaceuticals a private or public company?

    Centrient Pharmaceuticals is a Private company.

  • What is Centrient Pharmaceuticals’s current revenue?

    The current revenue for Centrient Pharmaceuticals is .

  • How much funding has Centrient Pharmaceuticals raised over time?

    Centrient Pharmaceuticals has raised $1B.

  • Who are Centrient Pharmaceuticals’s investors?

    Bain Capital, Ergo Partners, and Planet B.io have invested in Centrient Pharmaceuticals.

  • Who are Centrient Pharmaceuticals’s competitors?

    Sayre Therapeutics, MSN Laboratories, Glenmark Pharmaceuticals, Intas Pharmaceuticals, and Paratek Pharmaceuticals are some of the 9 competitors of Centrient Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process